[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571857":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":29,"responsibleParty":79,"collaborators":82,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":88,"acronym":10,"eligibilityCriteria":89,"healthyVolunteers":90,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":97,"studyType":98,"phases":10,"briefSummary":99,"conditions":100,"keywords":104,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group Assignment",null,"Each subject receive a single intravenous injection of 18F-92\u002FAV45, 11C-PIB and undergo PET\u002FCT or MRI imaging within the specificed time.",[13],"Diagnostic Test: 18F-92\u002FAV45, 11C-PIB",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","18F-92\u002FAV45, 11C-PIB",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Ying Wang, MD","CONTACT","+8618702292537","macrossplusvoices@163.com",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Li Cai, MD","+862260362190","xcl242004@126.com",[30,51,67],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"The First Affiliated Hospital of University of Science and Technology of China","RECRUITING","Hefei","Anhui","230000","China","CN",{"type":39,"coordinates":40},"Point",[41,42],117.28083,31.86389,{"lat":42,"lon":41},[45,49],{"name":46,"role":22,"phone":47,"phoneExt":10,"email":48},"Qiang Xie, PhD","+8613721108043","ahxq1980@163.com",{"name":46,"role":50,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":52,"status":32,"city":53,"state":54,"zip":55,"country":36,"countryCode":37,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Chinese PLA General Hospital,","Beijing","Beijing Municipality","100853",{"type":39,"coordinates":57},[58,59],116.39723,39.9075,{"lat":59,"lon":58},[62,66],{"name":63,"role":22,"phone":64,"phoneExt":10,"email":65},"Yan Chang, MD","+8618210830630","cyneurology@163.com",{"name":63,"role":50,"phone":10,"phoneExt":10,"email":10},{"facility":68,"status":32,"city":69,"state":70,"zip":71,"country":36,"countryCode":37,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Tianjin Medical University General Hospital","Tianjin","Tianjin Municipality","300052",{"type":39,"coordinates":73},[74,75],117.17667,39.14222,{"lat":75,"lon":74},[78],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":50,"investigatorFullName":80,"investigatorTitle":81,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Shaobo Yao, PhD","Prof.",[83],{"name":68,"class":6},"100571857","beta-amyloid-petct-in-various-a-related-disease-100571857",false,"NCT06725706","Beta Amyloid PET\u002FCT in Various Aβ-Related Disease","Inclusion Criteria:\n\n\\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled Aβ PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n\\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":95,"type":96},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 18F-92\u002FAV45, 11C-PIB positron emission tomography\u002Fcomputed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.",[101,102,103],"Amyloid","Beta-Amyloid","Neurodegenerative Diseases",[105,106,102],"PET\u002FCT","MRI","2025-06-03",{"date":109,"type":110},"2025-06-04","ACTUAL",{"date":112,"type":110},"2012-09-01",{"date":114,"type":96},"2027-12-01",{"name":5,"class":6},3]